Capital raised by Enveric Biosciences
1 Form D filing · first filed Apr 2026 · Cambridge, MA
Chief Executive Officer
Signatory on Enveric Biosciences's Form D filings · $5.0M raised across 1
Joseph E. Tucker is on file as Chief Executive Officer at Enveric Biosciences in Cambridge, MA. Enveric Biosciences has 1 Form D filing on record, $5.0M raised in total. Joseph E. Tucker appears as a signatory on the company's filings.
Lead small-molecule neuroplastogen candidate, the first known compound designed to selectively engage both the 5-HT2A and 5-HT1B receptors. It is being advanced toward an FDA pre-IND meeting and IND submission, with first-in-human trials planned for 2026 in difficult-to-treat mental health disorders.
